TNF-α gene polymorphism and fetal Doppler velocimetry in intrauterine growth restriction

Neuroendocrinology Letters

Volumn 29, Issue 4, 2008, Pages 493-499

  Seremak Mrozikiewicz, Agnieszka ^a   Dubiel, Mariusz ^a   Drews, Krzysztof ^a   Gudmundsson, Saemundur ^b   Mrozikiewicz, Przemyslaw M ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Research Institute of Medicinal Plants   (Poland)

Author keywords

Doppler velocimetry; Genetic polymorphism; Intrauterine growth restriction; Tumour necrosis factor alpha

Indexed keywords

ADENOSINE; GUANOSINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS MONITORING; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; IMMUNOELECTROPHORESIS; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM; MIDDLE CEREBRAL ARTERY; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UMBILICAL ARTERY;

EID: 54349092352     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Styne DM (1998). Fetal growth. Clin Perinatol. 25: 917-938.
2. Marsal K (2002). Intrauterine growth restriction. Curr Opin Obstet Gynecol. 14: 127-135.
3. Mandruzzato GP, Meir YJ, Maso G, Conoscenti G, Rustico MA (2003). Monitoring the IUGR fetus. J Perinat Med. 31: 399-407.
4. Stallmach T, Hebisch G, Joller-Jemelka HI, Orban P, Schwaller J, Engelmann M (1995). Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease. Lab Invest. 73: 384-392.
5. Bartha JL, Romero-Carmona R, Comino-Delgado R (2003). Inflamatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand. 82: 1099-1102.
6. Heyborne KD, Witkin SS, McGregor JA (1992). Tumor necrosis factor-alpha in midtrimester amniotic fluid is associated with impaired intrauterine fetal growth. Am J Obstet Gynecol. 167: 920-925.
7. Old LJ (1985). Tumor nrecrosis factor (TNF). Science. 230: 630-632.
8. Winkler M (2003). Role of cytokines and other inflammatory mediators. BJOG. 110: 118-123.
9. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarret-Nedwin J, Pennica D, et al (1985). Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13: 6361-6373.
10. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, et al (1998). Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Europ J Clin Invest. 28: 59-66.
11. Knight JC, Udalova I, Hill AVS, Greenwood BM, Peshu N, Marsh K, et al (1999). A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nature Genet. 22: 145-150.
12. Gudmundsson S, Marsal K (1988). Umbilical and uteroplacental blood flow velocity waveforms in pregnancies with fetal growth retardation. Eur J Obstet Gynecol Reprod Biol. 27: 187-196.
13. Mari G, Deter RL (1992). Middle cerebral artery flow velocity waveforms in normal and small for gestational age fetuses. Am J Obstet Gynecol. 166: 1262-1270.
14. Hayashi M, Ohkura T (2002). Elevated levels of serum macrophage colony-stimulating factor in normotensive pregnancies complicated by intrauterine fetal growth restriction. Exp Hematol. 30: 388-393.
15. Holcberg G, Huleihel M, Sapir O, Katz M, Tsadkin M, Furman B, et al (2001). Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol. 94: 69-72.
16. Dubiel M, Seremak-Mrozikiewicz A, Breborowicz GH, Drews K, Pietryga M, Gudmundsson S (2005). Fetal and maternal Doppler velocimetry and cytokines in high-risk pregnancy. J Perinat Med. 33: 17-21.
17. Arntzen KJ, Kjollesdal AM, Halgunset J, Vatten L, Austgulen R (1998). TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J. Perinat Med. 26: 17-26.
18. Belady PH, Farkouh LJ, Gibbs RS (1997). Intra-amniotic infection and premature rupture of membranes. Clin Perinatol. 24: 43-57.
19. Weiyuan Z, Li W (1998). Study of interleukin-6 and tumor necrosis factor-alpha levels in maternal serum and amniotic fluid of patients with premature rupture of membranes. J Perinat Med. 26: 491-494.
20. Rosmond R, Chagnon M, Bouchard C, Bjorntorp P (2001). G-308A polymorphism of the tumor necrosis factor alpha gene promoter and salivary cortisol secretion. J Clin Endocr Metab. 86: 2178-2180.
21. Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG (1999). Circulating tumor necrosis factor-alpha concentrations in a Native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocr Metab. 84: 272-278.
22. Mulcahy B, Waldron-Lynch F, McDermott MF, Adams C, Amos CI, Zhu DK, et al (1996). Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet. 59: 676-683.
23. Ota N, Hunt SC, Nakajima T, Suzuki T, Hosoi T, Orimo H, et al (2000). Linkage of human tumor necrosis factor-alpha to human osteoporosis by sib-pair analysis. Genes Immunity. 1: 260-264.
24. Escobar-Morreale HF, Calvo RM, Sancho J, San Millan JL (2001). TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J Clin Endocr Metab. 86: 3761-3767.
25. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, et al (2001). Association between polymorphism in regulatory region of gene encoding tumour necrosis factor-alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 357: 436-439.
26. Kruger R, Hardt C, Tschenscher F, Jackel S, Kuhn W, Muller T, et al (2000). Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm. 107: 553-562.
27. Wilson A, Symons J, McDowell T, McDevitt H, Duff G (1997). Effects of a polymorphism in the human tumour necrosis factor a promoter on transcriptional activation. Proc Nat Acad Sci. 94: 3195-3199.
28. Johnson MR, Anim-Nyame N, Johnson P, Sooranna SR, Steer PJ (2002). Does endothelial cell activation occur with intrauterine growth restriction? BJOG. 109: 836-839.